Ушбу иш иқтибос қилган ишлар

91 та иш

Иш: Serum tyrosine associates with increased CSF Aβ42, reduced Aβ deposition, and cognitive improvement in MCI: modulation by confounding factors

1. Comprehensive and Neuropsychologic Evaluations

   Richard C. Mohs

   Шарҳ мақола19964 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.775807

2. Escala de Avaliação da Doença de Alzheimer - Subescala Cognitiva (ADAS-Cog): Dados Normativos para a População Portuguesa

   Joana Nogueira, Sandra Freitas, Diana Duro +4

   Мақола20184 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.775825

3. The duality of amyloid-β: its role in normal and Alzheimer’s disease states

   Ali Azargoonjahromi

   Шарҳ мақола20244 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.775861

4. Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

   Donovan McGrowder, Fabian Miller, Kurt Vaz +9

   Шарҳ мақола20213 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.292518

5. CSF Amyloid-β42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism

   Ali Azargoonjahromi, Hamide Nasiri, for the Alzheimer’s Disease Neuroimaging Initiative#

   Мақола20253 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.775873

6. ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

   Takahisa Kanekiyo, Huaxi Xu, Guojun Bu

   Шарҳ мақола20142 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.292451

7. ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

   Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier +3

   Шарҳ мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.339258

8. A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s disease

   Youssra K. Al‐Hilaly, Thomas L. Williams, Maris Stewart-Parker +8

   Мақола20132 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.744555

9. CSF biomarkers for Alzheimer's disease: current utility and potential future use

   David M. Holtzman

   Мақола20112 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.775788

10. Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

    Ruth Motter, Carmen Vigo‐Pelfrey, Dora Kholodenko +14

    Мақола19952 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775789

11. <scp>CSF</scp> A<i>β</i>42/A<i>β</i>40 and A<i>β</i>42/A<i>β</i>38 ratios: better diagnostic markers of Alzheimer disease

    Shorena Janelidze, Henrik Zetterberg, Niklas Mattsson +9

    Мақола20162 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775815

12. Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline

    Ali Azargoonjahromi

    Шарҳ мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775860

13. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775787

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775790

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775791

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775792

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775793

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775794

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775795

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775796

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775797

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775798

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775799

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775800

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.775801